Published September 2002 | Version v1
Journal article

Semiquantitative SPECT myocardial perfusion with dipyridamole in patients unable to exercise. Event rate during 4 years of follow up

  • 1. Universidad Catolica de Cordoba, Cordoba (Argentina)
  • 2. FUCCADIM, Cordoba (Argentina)
  • 3. Laboratorio de Medicina Nuclear - Instituto Modelo de Cardiologia, Cordoba (Argentina)
  • 4. Instituto de Estadisticas y Demografia de la Facultad de Ciencias Economicas de la Universidad Nacional de Cordoba, Cordoba (Argentina)

Description

The increasingly numbers of patients (P) that can't reach an adequate level of exercise in order to evaluate CAD, lead us to use pharmacological and technical tools available for this subgroup of P. Aim: evaluate the prognostic significance of myocardial perfusion SPECT imaging with pharmacological stress in P without LBBB, unable to exercise. Material and Methods: 209 P were included. Mean age: 65 years old (39-88), male 66%. Clinical: Pre test likelihood <= 20%: 36.4 %, 21-75%: 15.8%, 76-99%: 8.1%, known CAD: 39.7%; Risk Factors: High blood pressure (BP): 70%, diabetes: 23%, cholesterol: 49%, smokers: 39%; EKG: scar 18%. Stress test: dipyridamole: 0.56 mg/kg/4 min.; analyzed variables: D heart rate (HR), D BP, cardiac and non cardiac side effects. Myocardial Perfusion SPECT: semiquantitative analysis to evaluate perfusion defects with a 20-segment model and 5-point scoring system for uptake reduction. Scintigraphic indices SSS (sum of stress scores), SRS (sum of rest scores) and SDS (SSS-SRS). Follow up: soft cardiac events (SCE): need for PTCA or CABG, unstable angina, heart failure; hard cardiac events (HCE): non-fatal acute myocardial infarction and cardiac death. Results: I) Pharmacologic stress test: D HR 27%; D systolic BP 3%; D diastolic BP 1%; non cardiac side effect: headache 13%, dyspnea 9%, nausea 0.5%; cardiac side effect: angina 21%, ST download 6%, atrial fibrillation 3%, severe ventricular arrhythmia 1.5%. II) Image analysis: SSS 0-3: 54.3%, SSS 4-8: 17.7%, SSS >8: 28%; SDS 0 and SRS 0: 31.7%; SDS 0 + SRS >=1: 21%; SDS >=1: 47.3%. III) Follow up: 13 patients were early re-vascularized induced by SPECT study results, 10 patients get lost and 186 were follow up by a mean 1086 days. Cumulative events rate: 1st year SCE 9.7%, HCE 1.6%; 2nd year SCE 14%, HCE 4.3%; 3rd year SCE 17.7%, HCE 5.4%; 4th year SCE 21%, HCE 5,4%. Scintigraphic indices and events rate relationship are presented. Conclusion: There was a relationship between scintigraphic indices and hard cardiac events. The semiquantitative myocardial perfusion with dipyridamole stress was a safe test and useful to discriminate groups of P with different risk of events

Additional details

Publishing Information

Journal Title
World Journal of Nuclear Medicine
Journal Volume
1
Journal Issue
suppl.2
Journal Page Range
p. 206-207
ISSN
1450-1147

Conference

Title
8. Congress of the World Federation of Nuclear Medicine and Biology
Dates
29 Sep - 2 Oct 2002
Place
Santiago (Chile)

INIS

Country of Publication
International Atomic Energy Agency (IAEA)
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
34035509
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
Conference
Descriptors DEI
CARDIOVASCULAR DISEASES; CORONARIES; IMAGE PROCESSING; MYOCARDIUM; PERFUSED ORGANS; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY
Descriptors DEC
ARTERIES; BLOOD VESSELS; BODY; CARDIOVASCULAR SYSTEM; COMPUTERIZED TOMOGRAPHY; COUNTING TECHNIQUES; DIAGNOSTIC TECHNIQUES; DISEASES; EMISSION COMPUTED TOMOGRAPHY; HEART; MUSCLES; ORGANS; PROCESSING; RADIOISOTOPE SCANNING; TOMOGRAPHY

Optional Information

Notes
1 tab